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Abstract
Background: Chronic lung diseases (CLDs), responsible for 4 million deaths globally every year, are increasingly
important in low- and middle-income countries where most of the global mortality due to CLDs currently occurs.
As existing health systems in resource-poor contexts, especially sub-Saharan Africa (SSA), are not generally oriented
to provide quality care for chronic diseases, a first step in re-imagining them is to critically consider readiness for
service delivery across all aspects of the existing system.
Methods: We conducted a mixed-methods assessment of CLD service readiness in 18 purposively selected health
facilities in two differing SSA health system contexts, Tanzania and Sudan. We used the World Health Organization’s
(WHO) Service Availability and Readiness Assessment checklist, qualitative interviews of key health system
stakeholders, health facility registers review and assessed clinicians’ capacity to manage CLD using patient vignettes.
CLD service readiness was scored as a composite of availability of service-specific tracer items from the WHO
service availability checklist in three domains: staff training and guidelines, diagnostics and equipment, and basic
medicines. Qualitative data were analysed using the same domains.
Results: One health facility in Tanzania and five in Sudan, attained a CLD readiness score of ≥ 50 % for CLD care.
Scores ranged from 14.9 % in a dispensary to 53.3 % in a health center in Tanzania, and from 36.4 to 86.4 % in
Sudan. The least available tracer items across both countries were trained human resources and guidelines, and
peak flow meters. Only two facilities had COPD guidelines. Patient vignette analysis revealed significant gaps in
clinicians’ capacity to manage CLD. Key informants identified low prioritization as key barrier to CLD care.
Conclusions: Gaps in service availability and readiness for CLD care in Tanzania and Sudan threaten attainment of
universal health coverage in these settings. Detailed assessments by health systems researchers in discussion with
stakeholders at all levels of the health system can identify critical blockages to reimagining CLD service provision
with people-centered, integrated approaches at its heart.
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Introduction
Chronic lung diseases (CLDs) are diseases of the airways
and structures of the lung including asthma, chronic ob-
structive pulmonary disease (COPD), bronchiectasis, oc-
cupational lung diseases and pulmonary hypertension
[1]. They are responsible for a high burden of morbidity
- especially from poorly controlled asthma - and mortal-
ity – especially from COPD – causing around 4 million
deaths globally every year [2]. Post-tuberculosis lung dis-
ease (PTLD) is also increasingly recognised as an im-
portant cause of CLD, especially in high TB burden
settings [3, 4]. An estimated 500 million people lived
with CLD in 2017, an increase of 40 % compared to
1990 [5]. This has resulted in increased mortality -
COPD is now the third most common cause of death
globally [6]. COPD is expected to increase further as
populations continue to age, including in low- and
middle-income countries (LMICs) where 90 % of the
global COPD mortality currently occurs [7] and the
population is exposed to biomass use, smoking and oc-
cupational risk factors [8]. Though data are sparse, a sys-
tematic review of nine cross sectional studies from sub-
Saharan Africa (SSA) showed prevalence of COPD ran-
ging from 4.1 − 24.8 % [9]. Similarly, a review showed a
wide variation in prevalence of asthma from 9.1 % in
Ethiopia to 20.3 % in South Africa [10]. Interpretation of
this variability is confounded by differences in study
methodology and diagnostic approaches. This further af-
fects recognition of the true burden of CLD.
CLDs therefore remain under recognised and poorly
prioritised within the health systems in sub-Saharan Af-
rica [11], with a paucity of data to guide decision making
and policy by health systems stakeholders on manage-
ment of CLDs in this setting. In Tanzania, data on CLD
prevalence, diagnosis, management, and outcome are
limited. A study of asthma among adolescents revealed
prevalence of 17.6 and 6.4 % in urban and rural areas re-
spectively [12]. Similarly, the prevalence of COPD in
western rural Tanzania was found to be 18 % with a
higher prevalence among men than women [13]. In
Sudan, asthma incidence is rising among children in
Khartoum state and the prevalence among adults was es-
timated to be around 10 % [14]. Unpublished CLD data
has shown a COPD prevalence of 16.5 % in urban Sudan
and a restrictive lung function was found in 55.6 % of
adults who underwent spirometry. In addition, both
Tanzania (high) and Sudan (moderate) have significant
TB burdens which further increases the burden of CLDs
as an association between TB and CLDs has been estab-
lished [15, 16].
Existing systems are not generally oriented to provide
quality care for CLD, especially with regard to chronic
illness management [17]. A first step in re-imagining
them is to critically consider readiness across all aspects
of the existing system and how they interconnect [18]. It
remains unclear how ready the health systems are to de-
liver quality CLD care in these settings. Several studies
have examined the state of preparedness of health sys-
tems in LMICs to deliver general health services, specific
disease services or primary health care in the context of
universal health coverage [19–22]. Studies investigating
preparedness for CLD services are however rare. A re-
cent study found varied availability of spirometry and
World Health Organization (WHO) essential medicines
for COPD and asthma in Africa [23]. As part of a parent
project exploring integration of CLD services into exist-
ing public health services, we assessed the readiness of
health systems to deliver specialised CLD services in
Tanzania and Sudan two different sub–Saharan African
countries.
Methods
This was a cross-sectional, mixed methods study that
combined qualitative key informant interviews and
healthcare worker in-depth interviews with a readiness
assessment checklist, and review of TB registers and
health facility records. Qualitative interviews were con-
ducted to gain a detailed and nuanced description of the
experiences of key health system players related to the
characterization, prioritization and management of
Chronic lung diseases. Clinical vignettes were included
in the healthcare workers in-depth interviews to measure
the knowledge of clinicians about CLD while at the same
time measuring their skills in diagnosing and managing
the condition.
Health system contexts
The Sudan health system is administered at three levels:
Federal, State and Locality [24]. Within Localities, Pri-
mary Health Services are provided at health centers in
urban and rural settings, while within States, district
hospitals provide secondary as well as referral services.
National hospitals and State teaching hospitals provide
tertiary care.
In Tanzania, the health system is administered as a
pyramidal structure at five levels: the national, zonal, re-
gional, district and ward/village levels. Primary health
care services, the base of the pyramid, are provided at
the ward/village level by health centers and dispensaries.
Secondary health services are provided at the district
level by the district hospitals while regional hospitals
provide specialist referral services. Community-based
health activities bring health promotion and prevention
to families in villages or streets, often along with the
support of vertical disease control programs, including
the national TB program.
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Study sites
The study locations, Gezira State in Sudan and Dodoma
region of Tanzania, were selected in collaboration with
local Ministries of Health to allow “best-case” assess-
ments. Gezira State was selected because of an existing
pilot offering integrated services focusing on asthma
standard case management. These services were devel-
oped by the Epidemiological laboratory (EPILAB), a
research NGO with research infrastructure in Gezira
collaborating in this study. Gezira state Ministry of
Health has shown a strong interest in extending the
existing pilot services. Dodoma Region was selected
due to the strength of its TB Program and its strong
community-based referral system for TB. In Tanzania,
ten health facilities were purposively selected for
readiness assessment to ensure inclusion of all health
system levels, health facilities with and without TB
diagnostic services, government-owned and non-
government owned facilities, and both urban and
rural settings. The participating sites were: one re-
gional hospital, one district hospital, four health cen-
ters and four dispensaries. In Sudan eight district
level facilities were selected: four where EPILAB
asthma standard case management program is oper-
ational (‘EPILAB sites’) and 4 where this program is
not yet operational (‘non EPILAB sites’); all eight
were government owned as there were no privately
owned health facilities in the study area at the same
level as district hospitals. As a major objective of our
study in Sudan is to scale up the existing asthma
standard case management program to non EPILAB
sites, only district level health facilities were selected.
Furthermore, the district health facilities in Sudan re-
ceive direct referrals from the community and serve
as the ‘close-to-community’ facilities equivalent to
health centers in Tanzania.
Readiness assessment and registers reviews
A structured assessment checklist based on the WHO
Service Availability and Readiness Assessment (SARA)
manual [25], was used to assess availability of human re-
sources, treatment guidelines, drugs, equipment and
community linkages in the facilities. All reported guide-
lines, equipment and medicines were visually checked.
Readiness to deliver CLD services was defined as the
ability of a health facility to provide out-patient care for
chronic lung diseases, in accordance with the WHO
SARA manual [25]. This was based on 3 domains of ser-
vice availability and readiness:
 Staff training and guidelines: facility must have a
guideline for CLD and the presence of at least one
staff who received a refresher or in-service training
on management of CLD in the past 2 years.
 Diagnostics and Equipment: facility must report
availability of 4 equipment – peak flow meter,
spacer devices, stethoscope and oxygen cylinder.
 Basic medicines: facility must report availability of 5
basic medicines - injectable epinephrine,
hydrocortisone, prednisolone tablets, salbutamol and
beclomethasone or other steroid inhaler.
Other equipment whose availability and functionality
were explored included nebulizer with mask, pulse ox-
imeter, sputum cups and glass slides.
Out-patient registers were reviewed in all facilities in
both countries to identify CLD patients seen in the facil-
ities in the previous month. In addition, records of the
previous two years of the TB registers were reviewed in
the TB clinics of 9 of the health facilities in Tanzania to
determine the numbers diagnosed with TB and those
without a TB diagnosis who could potentially have CLD.
Any diagnosis of Asthma, Chronic Obstructive Pulmon-
ary Disease (COPD), Chronic bronchitis, Bronchiectasis,
Post TB lung disease or Occupational lung disease, was
regarded as CLD. Diagnosis of these conditions was
based on local practices including, clinical judgment of
clinicians, limited investigations (where possible) and
standard treatment guidelines.
Participant selection for qualitative interviews
For the qualitative component, in-depth interviews
(IDIs) were conducted with care providers, one from
each of the selected health facilities in both countries.
Healthcare workers were purposively identified from
each health facility and included those who provided ser-
vices for CLD patients such as medical doctors, non-
medical doctor clinicians and nurses. In Tanzania, this
included the TB focal persons and clinicians working in
the specialised NCD clinic as CLD diagnosis is usually
through TB clinic and the follow up conducted at the
NCD clinic. In Sudan, selected healthcare workers in-
cluded medical doctors and medical assistants.
Key informant interviews (KIIs) were conducted with
purposively selected health system stakeholders from na-
tional, regional (or state in Sudan) and district levels and
with in-depth knowledge of TB and CLD based on their
job role.
Data collection and analysis
All data were collected by authors (ES, RO, BN, HI) and
research assistants trained in line with WHO SARA rec-
ommendations (WHO SARA ref, page 26 s. 1.5). Train-
ing covered overall aims of the study, data quality,
facility data capture tools, how to administer question-
naire and record responses, ethical issues in health facil-
ity research, informed consent administration, privacy
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and confidentiality. Training included hands-on practical
sessions and a data collection pilot in the health facility.
For the readiness assessment, research assistants vis-
ited the health facilities and interviewed the person in-
charge of each facility using the structured readiness as-
sessment checklist. For each service, the readiness score
is computed as the mean availability of service-specific
tracer items in the 3 domains: staff training and guide-
lines, diagnostics and equipment, and basic medicines.
Equal weights are assigned to each of the 3 domains to
achieve a total possible score of 100 % (i.e. 33.3 % each
for staff training and guidelines, diagnostics and equip-
ment, and basic medicines). Equal weights are also
assigned to each domain indicator to contribute to the
final total domain score of 33.3 % (16.7 % for each indi-
cator in staff and training, 8.3 % for each indicator in
diagnostics and equipment, and 6.7 % for each indicator
in basic medicines).
Two levels of service readiness were defined:
 High readiness – health facility scored at least 50 %
of the indicators in each of 3 domains.
 Low readiness – health facility scored less than 50 %
of the indicators in each of 3 domains.
We presented service availability and readiness levels
by facility and compared them across facilities and coun-
try where applicable. We performed simple descriptive
analysis of the other quantitative data, with health facil-
ities as units of analysis using frequencies.
Healthcare worker interviews used a structured topic
guide to explore questions around knowledge and man-
agement of CLD and included a patient vignette to as-
sess current skills and knowledge of CLD management
and guidelines. The vignette simulated an outpatient
consultation with a 60-year-old man with features of
CLD, with specific questions posed to respondents about
history, examination, diagnosis, treatment, and manage-
ment of the patient. Respondents were requested to an-
swer the questions and to fill an asthma diagnosis and
treatment card at the end if their diagnosis was asthma.
They were assured that this was not a test and that the
result would not be shared with their supervisors or
colleagues.
Similarly, key informant interviews were conducted
using structured topic guides to explore overall readiness
and topics including stakeholders’ prioritization of CLD
services, service delivery, health workforce and the bar-
riers to diagnosis and management of CLD patients.
Key informants and healthcare workers were inter-
viewed at their offices and workspaces at a convenient
time for them. Interviews were conducted in Arabic in
Sudan, and in Swahili in Tanzania. All interviews were
audio taped, transcribed verbatim and finally back
translated into English by independent professional
translators. The data was coded and analysed using a
thematic framework approach [26].
Ethical considerations
The study was approved by the ethics committees of
National Institute for Medical Research, Tanzania (ref
/Vol.IX/2922); the Ministry of Health of Gezira state,
Sudan (ref 44/T/KH/1) and the Liverpool School of
Tropical Medicine (ref 18–043). Permission was also
sought from the respective district authorities. Written
informed consent was obtained from all participants in
the qualitative interviews and from the in-charge of
health facilities prior to the readiness assessment inter-
view and completion of the checklist.
Results
Characteristics of health facilities
Altogether, 18 health facilities were visited for readiness
assessment, 10 in Tanzania and 8 in Sudan.




Nurses made up the majority of healthcare workers ob-
served in the health facilities [38/109 (34.9 %) vs. 43/103
(41.7 %)] whilst assistant medical officers/medical assis-
tants were the least available [8/109 (7.3 %) vs. 6/103
(5.8 %)] in Tanzania and Sudan respectively. Clinical offi-
cers and medical attendant cadres were unique to
Tanzania (Fig. 1).
Table 1 Characteristics of health facilities assessed for readiness
for chronic lung disease services in Tanzania and Sudan
Tanzania (n=10) Sudan (n=8) Total
Type of facility
Regional hospital 1 0 1
District hospital 1 8 9
Health centre 4 0 4
Dispensary 4 0 4
Managing authority
Government/public 8 8 16
Mission/ faith-based 2 0 2
Private/NGO 0 0 0
Location
Urban 1 1 2
Rural 9 7 16
Outpatient services only
Yes 4 0 4
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In Tanzania, clinical officers, nurses, and pharmacists/
pharmacy technicians were the only healthcare staff
cadres available in all facilities. All cadres were available
at regional, district and health center levels. Of 21 med-
ical doctors available on the day of facility visit, 16
(76.2 %) were at the regional hospital whilst only one
(4.8 %) was at the health centers. Most of the nurses (15/
38) were present at the district hospital. In Sudan, 19
medical doctors overall were present in all health facil-
ities observed, with seven (36.8 %) of these in just one fa-
cility. Nurses and pharmacists/pharm tech were present
in all health facilities.
Infrastructure and basic amenities
Outpatient-only services were offered at the four dis-
pensaries in Tanzania. In the six facilities offering in-
patient services, the bed capacity ranged from 22 in one
of the health centers to 450 in the regional referral hos-
pital. A functional ambulance for emergency transporta-
tion was available and operated from the facility in the
regional hospital, the district hospital and in two of the
health centers, but all health centers and dispensaries
had access to a functional ambulance from another facil-
ity. A drug store was available in all facilities except two
health centers and one dispensary. In Sudan, all facilities
offered both inpatient and outpatient services and were
equipped with drug stores with sufficient space. Bed cap-
acity ranged from nine in the smallest facility to 128 in
the largest. A functional ambulance was available in
seven facilities, but three of the seven ambulance vehi-
cles had no fuel on day of observation.
Service operation
A total of 19,812 OPD visits were recorded in all 10
health facilities in Tanzania over a period of one month,
most of which occurred at the regional hospital. All 80
outpatient presumed TB cases were seen at two health
centers and two dispensaries; 77 of these were found to
be negative for TB. TB clinic registers reviewed in nine
health facilities in Tanzania showed that 7,292 clients
with presumed TB were investigated for TB over the
previous two years; 955 (13.1 %) of these were diagnosed
with TB whilst 6,355 (87.2 %) were TB negative. TB re-
cords were not available in one dispensary and therefore
not reviewed in this facility. In contrast only two OPD
visits were recorded for COPD over one-month period
in all 10 facilities and this was at a health center.
In Sudan, 12,509 OPD visits overall were recorded in
all 8 health facilities over the one-month review period.
Asthma was responsible for 273 (2.2 %) of all OPD visits
with 58 (21.2 %) of these in the four health facilities
(‘EPILAB sites’) where EPILAB’s asthma management
program is operational. There was no OPD visit identi-
fied as COPD over one-month period in any of the
health facilities. Of the 38 presumed TB cases seen in six
of the eight facilities, 13 were found to be negative for
TB.
In both countries, asthma was far more likely to be di-
agnosed than COPD (119 vs. 2 in Tanzania, 392 vs. 0 in
Sudan, respectively) during OPD visits. Of 32,321 total
outpatient visits in one month across all 18 health facil-
ities, only 2 was for COPD; this was in in a health center
in Tanzania. The proportion of presumed TB among
OPD visits is similar (0.4 % vs. 0.3 % in Tanzania and
Fig. 1 Human resource for generalised care as a percentage of all staff present on day of observation by cadre in Tanzania and Sudan
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Sudan respectively), but the proportion of these patients
shown to be TB negative was much higher in Tanzania
(87.2 %) than in Sudan (34 %, 13/38). No final diagnosis
on the TB negative patients could be traced and no diag-
nosis of post TB lung disease was found. A detailed ana-
lysis of the OPD visits is available as supplementary
material (Additional file 1).
CLD service readiness
Staff availability and training
No healthcare staff had received in-service or refresher
training for CLD in any health facility in Tanzania in the
past two years. However, four doctors, seven clinical offi-
cers and six nurses received pre-service training in CLD.
In Sudan, staff who received in-service training in CLD
were available in only 4 of the 8 health facilities. In three
of these facilities, 1 doctor and 1 nurse were trained
whilst just 1 doctor was trained in the remaining facility.
Additionally, a medical assistant was trained in two of
the facilities. No other cadre of staff received training in
CLD.
Guidelines
In Tanzania, guidelines were more likely to be available
at the health centers and dispensaries. None of the 10
guidelines identified as relevant in the study were avail-
able at either the regional or district hospitals. Only two
facilities (one health center and one dispensary) had
asthma guidelines. A COPD guideline was available in
one health center. In Sudan, on the other hand, guide-
lines were more widely available. Asthma guidelines
were available in five (62.5 %) of the eight health facil-
ities, whilst pneumonia guidelines were available in four
(50 %) facilities. In contrast, only 1 facility had a COPD
guideline. A full list of the relevant guidelines and data
on their availability in the health facilities are available
as supplementary material (Additional file 2).
Equipment
In Tanzania, of all required essential equipment includ-
ing peak flow meter, spacer devices, stethoscope and
oxygen cylinder, only peak flow meters were unavailable
in the regional and district hospitals. Stethoscopes were
the only essential CLD equipment available in all facil-
ities. In Sudan, all four items of equipment were avail-
able and functional in one facility, three in four facilities,
and two in each of the remaining three facilities.
Nebulisers were available in two of the 10 facilities in
Tanzania, and in seven of the eight facilities in Sudan.
Sputum containers and microscope slides were available
across all health facilities whilst oxygen sources were
available in all health facilities except dispensaries in
Tanzania.
Medicines
Salbutamol inhalers, epinephrine and hydrocortisone in-
jections were widely available in both Tanzania and
Sudan. On the other hand, steroid inhalers were not
widely available. In Tanzania, beclomethasone was avail-
able only at the regional hospital, which also had flutica-
sone inhalers. In Sudan, where essential CLD medicines
were more widely available, beclomethasone inhalers
were available in only three of the facilities; in two of
these three facilities, fluticasone and budesonide inhalers
were additionally available. While salbutamol solution
for nebulizer was available in all facilities in Sudan, it
was only available in the district hospital in Tanzania.
Prednisolone tablets were available in all health facilities.
Patient vignette
All clinicians who participated in the IDIs were offered
the patient vignettes as part of the interviews. Fifteen
healthcare workers, nine in Tanzania and six in Sudan,
responded to the patient vignette during the IDIs. Two
respondents in Tanzania were medical doctors, one at
the regional hospital and one at the district hospital.
One clinical officer declined. In Sudan, 2 medical doc-
tors declined.
Overall, the respondents could correctly elicit an
asthma history, describe the management of acute at-
tacks, correct use of inhaler and patient counseling. Be-
yond these, only the medical doctors went further with
the vignette. One medical doctor in Tanzania and five in
Sudan made an initial diagnosis of asthma. All 6 identi-
fied the correct treatment for an acute asthmatic attack
and antibiotic treatment for infections. Two medical
doctors from Sudan made an initial diagnosis of COPD.
However, when all doctors were presented with the next
scenario where the patient returned 8 days later with
persisting symptoms and new peak expiratory flow (PEF)
values, only two understood PEF variability and only one
of them could calculate it from the values provided.
While most doctors considered excluding TB, COPD
was not considered a differential diagnosis by any of
those that made an initial diagnosis of asthma. Three
doctors understood asthma severity grading but graded
differently. Similarly, only 3 doctors mentioned psycho-
logical assessment for low mood in the simulated pa-
tient. When requested to fill an asthma management
card, it was observed that asthma cards were not avail-
able in any of the health facilities in Tanzania. In Sudan,
asthma cards were available only at EPILAB sites and
the doctors were confident with completing them.
Readiness for CLD care at higher and lower health system
levels
We conducted a separate analysis of the readiness scores
in district level and above to compare CLD readiness
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across both countries at the higher health system level
(Table 2). Overall, five health facilities (three EPILAB
sites, two non EPILAB sites), all from Sudan, attained
high readiness for providing CLD services. In Sudan, the
lowest and highest scores were both at ‘EPILAB site’ fa-
cilities. No facility fulfilled all requirements for readiness
in all the domains assessed. Staff with in-service or re-
fresher training in CLD and beclomethasone inhaler
were the two commonest missing tracer items overall;
they were not available in 7 and 6 health facilities, re-
spectively. In contrast, oxygen source was available in
nine of the 10 facilities whilst stethoscope was available
in all health facilities.
Regarding CLD service readiness in health centers and
dispensaries in Tanzania, one health center attained a
total readiness score of 53.3 %. This health center had all
CLD guidelines explored in the study. Of the remaining
health facilities, four had scored 28.1 % each, two scored
21.1 % each and one scored 14.9 %. Overall, the average
CLD service readiness score was 28.7 % in Tanzania and
62.3 % in Sudan.
Barriers to CLD care identified by key informants
Twelve key informants were interviewed in Tanzania
whilst 13 were interviewed in Sudan. Key informants
from both countries identified two major barriers to
CLD care. First, CLDs were not regarded as priority dis-
eases. In both countries, key informants regarded prior-
ity diseases as those with international recognition
demonstrated by international funding and organized
into programs such as HIV and TB: “Such diseases at-
tract high attention from the government since they are
considered international programs, [so] have [the associ-
ated] weight, funds, international interest and evalu-
ation, etc” (KII 1, Federal, Sudan).
In Tanzania, none of the national level key informants
mentioned CLDs among diseases considered as priority.
NCDs, however, were mentioned as priority diseases but
only with reference to Hypertension, Diabetes and Can-
cer: “NCDs have masked these chronic lung diseases be-
cause we focus more on cancer, diabetes and
cardiovascular conditions…. [As such] there is no priority
especially when you meet NCD people, their focus is on
diabetes and hypertensive diseases” (KII, National,
Tanzania).
Other diseases regarded as a priority included those
commonly diagnosed in the outpatient departments
and known locally to cause high mortality such as
malaria and pneumonia in children, and maternal ill-
nesses: “Well, they have a high death rate, a high ad-
mission rate, and high frequency of patients, and they
require a lot of effort from the Ministry of Health. …
these are the standards we take into consideration, in
addition to the financial toll they exert on the State
and the government as a whole.”. (K11 2, State,
Sudan).
The second barrier identified by key informants was
lack of data and this was key to low prioritization
accorded CLD care by the authorities.
Table 2 CLD service readiness score (%) of regional and district level health facilities in Tanzania and Sudan
Readiness domain and indicators Tanzania Sudan
Regional District District1 District2 District3 District4 District5 District6 District7 District8
Human resources and guidelines
i. CLD refresher or in-service training 0 0 16.7 16.7 16.7 0 0 0 0 0
ii. Guideline for any of COPD, asthma or
chronic bronchitis
0 0 16.7 16.7 16.7 16.7 0 16.7 16.7 0
Equipment
peak flow meter 0 0 0 0 8.3 0 0 8.3 8.3 0
spacer devices 0 0 0 8.3 8.3 8.3 0 0 0 8.3
stethoscope 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3
oxygen cylinder 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3 0 8.3
Medicine
Inj. epinephrine 6.6 6.6 6.6 6.6 0 6.6 6.6 6.6 0 6.6
hydrocortisone injection 6.6 6.6 6.6 6.6 0 0 6.6 6.6 6.6 6.6
prednisolone tablets 6.6 6.6 6.6 6.6 6.6 0 0 6.6 6.6 6.6
salbutamol inhaler 6.6 6.6 0 6.6 6.6 6.6 6.6 0 0 0
beclomethasone inhaler 6.6 0 0 0 6.6 6.6 0 0 6.6 0
Total readiness score 49.7 43.1 69.8 84.7 86.4 61.4 36.4 61.3 53.1 44.8
Note: Total readiness score is the column total for all indicators in each of three domains (human resources and guidelines, equipment and medicine). Availability
of an indicator in a health facility is scored 16.7, 8.3 and 6.6 in the three domains, respectively. Non availability is scored 0. All scores are in %.
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“We can go to a policy-maker, and tell him or her that
I need money because patients have increased…questions
coming… to what extent have they increased? How much
money do you need? Will that intervention really work?
So, we must have data…if you have that then you can
convince them, for example, for diabetes and hyperten-
sion we have taken those steps” (KII 3, National,
Tanzania). Health care workers, on the other hand, men-
tioned barriers already evident from the readiness assess-
ment checklist. They mentioned lack of guidelines and
lack of training as the major barriers to CLD care. The
responses were similar in both countries.
Discussion
In this study, we explored the readiness of health facil-
ities to provide services for CLDs in two sub–Saharan
African countries with differing health system contexts.
We found that overall, no health facility fulfilled all the
requirements for a CLD service with widespread gaps in
human resources, guidelines, and equipment. However,
six health facilities (1 in Tanzania and 5 in Sudan)
attained high CLD service readiness. The high readiness
in Sudan appeared to be driven by the EPILAB sites with
existing asthma management programs. CLD was very
rarely diagnosed, and our patient vignette analysis re-
vealed significant gaps in capacity of clinicians to man-
age CLD. These findings were corroborated by
qualitative data which also highlighted a lack of CLD
data and low prioritization of CLD by health system ac-
tors, as barriers to CLD management.
Two previous studies in Tanzania have reported simi-
lar findings from a secondary data analysis of the 2014–
2015 Tanzania Service Provision Assessment survey
data. In one, only 10.9 % of over 700 facilities analysed,
had high readiness for CLD services, and less than 10 %
had at least one staff trained in management of CLDs
[20]. In another, the mean CLD service readiness score
of health facilities was 38.8 %, despite excluding facilities
that did not report provision of CLD services [27]. Both
studies found that CLD guidelines, peak flow meters and
beclomethasone inhalers were the least available tracers
for service readiness. These findings are similar in other
SSA contexts. In Ethiopia, a NCD service availability and
readiness assessment showed an average CLD readiness
score of health facilities of 27 % [28], similar to the Tan-
zanian average (28.7 %) in our study. The additional use
of patient vignettes in our study adds value by providing
a snapshot of clinicians’ capacity to manage CLDs, not
been reported by previous readiness studies. Addition-
ally, poor prioritization of CLD by policymakers as
shown in the key informant interviews reveals an im-
portant contributing factor for the poor readiness levels
observed in this study.
Our study in Sudan focussed only on district level
health facilities including those where an integrated ap-
proach to delivering a package of care for CLD is oper-
ational [29]. These facilities had peak flow meters and
were more likely to have asthma guidelines, both of
which were found to be frequently unavailable for CLD
care in sub–Saharan African contexts [30]. However, ex-
perience with asthma care and overall higher readiness
for CLD care did not translate to improved care of CLD
in general, as seen in failure of the facilities to diagnose
even a single case of COPD among over 12,000 adult pa-
tients seen over a month’s period. This highlights the
need for a more comprehensive CLD training and avail-
ability of specific COPD guidelines.
In our study, trained staff, CLD guidelines, peak flow
meters and beclomethasone inhalers were the most fre-
quently missing tracer items, similar to findings from
other studies [20, 27, 28, 31]. Lack of training is likely to
have impacted the capacity of healthcare workers to rec-
ognise and diagnose CLD, especially COPD. Training of
health professionals in respiratory disease has been iden-
tified as an important strategy in global control of
chronic lung diseases [32], and remains a major gap in
achieving and maintaining CLD service readiness in
Tanzania and Sudan.
Lack of guidelines and trained staff observed in this
study would lead to lack of capacity to recognise, diag-
nose and manage CLDs and therefore lack of data on
which to base funding and planning for CLD care. As
failure to provide funding for equipment and drugs
would further lead to failure to make diagnosis,a poten-
tial vicious cycle could result which perpetuates negli-
gence of CLD care within the health system and
increased morbidity and mortality.
As health systems in LMICs face an increasing burden
of NCDs, several studies have examined preparedness of
health systems for chronic disease management. In most
of these studies, service availability and readiness have
been lowest in the context of CLDs. For example, in
Uganda, health facilities were consistently less prepared
for CLD services compared to other chronic diseases in
most domains of service readiness [33]. Similarly, in a
review of NCD service availability in first referral level
hospitals in low-income countries, availability of medica-
tion and equipment for acute management was highest
in epilepsy (40– 95 %) and hypertension (28 – 83 %) and
lowest in asthma care (0–4 %) [34].This probably reflects
the systemic negligence and poor investment in CLD by
the health system as mentioned above. Of interest is the
relatively high readiness for HIV care in most of the
studies compared to NCDs. This probably reflects the
impact of well-funded programs and could provide a
model for strengthening CLD and other NCD services
for policy makers in LMIC settings [18].
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We found in Tanzania that health systems for CLD
were weaker at the lower levels despite good potential to
make a difference at this level. This has also been re-
ported in previous studies within and outside Tanzania
in the context of CLD [20, 27], hypertension and dia-
betes [19, 33]. This raises important equity concerns in
Tanzania where about 70 % of the population lives in a
rural setting [35] and are therefore served by the lower-
level health facilities. By contrast, lower-level facilities
are doing well in TB diagnosis. This creates the chal-
lenge of managing a large pool of chronic cough clients
who have been found to be TB negative. In Malawi, only
about 10 % of patients investigated in TB clinics were
found to have TB disease [36]. In our study, the pre-
sumed TB patients seen in OPD were seen in the health
centers and dispensaries. Of these, the 96 % who were
TB negative, should ideally have been investigated to ex-
clude CLD. There is therefore an urgent need for health
policy makers to invest in staff training, diagnostics, and
medicines to improve management of CLD patients in
these countries.
Limitations and strengths of the study
Our study did not use a standard survey strategy and the
relatively limited numbers of health facilities we studied
were purposively selected meaning our results may not
be nationally representative. Nevertheless, our findings
are consistent with studies in Tanzania and elsewhere
which followed rigorous survey methodology [20, 27,
28]. However, it is possible that we may have over-
estimated some aspects of readiness for CLD delivery.
For example the SARA manual did not include a spir-
ometer, an essential equipment in confirming the diag-
nosis of COPD [37]. Had this been included, none of the
facilities in Tanzania would have achieved high readi-
ness, whilst the high scoring facilities in Sudan would
have been only marginally ready. It is also worthy of
note that we have based the assessment of readiness of
facilities on observations made on the day of study. Our
use of vignettes to assess skill of clinicians may not ad-
equately assess real clinical practice where, more nu-
ances could impact clinicians’ responses and actions.
Furthermore, the WHO readiness score may be too
blunt an instrument to guide policy and planning as crit-
ical indicators that impact quality care such as staff
training or guidelines could be lacking in the presence of
‘high facility readiness’. Our findings therefore need to
be interpreted with caution.
However, our use of qualitative interviews allowed us
to gain further insights from health systems actors. In
addition, conducting the study across two African coun-
tries with differing health system contexts provided
cross-country learning opportunities for both countries,
and widened the scope of application of our study
findings. Finally, the study was carried out primarily to
inform development of interventions to integrate CLD
care into existing health system. Therefore, the purpos-
ive selection of health facilities across health system
levels where interventions are expected to be imple-
mented, may be seen as a strength.
Conclusions
Major gaps exist in service availability and readiness for
CLD care in Tanzania and Sudan and threaten attain-
ment of universal health coverage in these settings. Lack
of guidelines, trained healthcare staff, peak flow meters
and inhaled treatments (particularly bronchodilators and
corticosteroids) for chronic airways diseases remain the
most pressing need for facility readiness for CLD care
across the health system. Detailed assessments by health
systems researchers in discussion with stakeholders may
be useful to identify critical blockages to re-orienting, or
reimagining service provision with people-centered, inte-
grated approaches at its heart.
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